Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SLNO | SOLENO THERAPEUTICS INC | $52.95 | $40.58 | 30.47% | 132.38x | 13.15x | 14.13x | 6.07x | 0.48x | $46.73M | 1.74% | $450.12M | 8.86 | $2.72B | 93.69 | ||
| GYRE | GYRE THERAPEUTICS INC | $7.07 | $4.39 | 61.14% | 117.83x | -21.66x | 5.42x | 6.47x | 0.61x | -$150.00k | -0.03% | $106.03M | 1.19 | $649.40M | 50.57 | ||
| ADMA | ADMA BIOLOGICS INC | $8.47 | $11.95 | -29.12% | 12.28x | 8.53x | 3.92x | 5.03x | 0.36x | $107.90M | 5.40% | $390.33M | 1.65 | $2.02B | 9.13 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $295.91 | $100.17 | 195.41% | 67.87x | 41.73x | 9.17x | 36.74x | 1.35x | $641.34M | 1.63% | $1.08B | 8.09 | $40.77B | 44.10 | ||
| CORT | CORCEPT THERAPEUTICS INC | $51.05 | $16.45 | 210.29% | 110.98x | 94.08x | 6.93x | 8.59x | 1.27x | $119.79M | 2.25% | $637.99M | 6.11 | $5.38B | -783.75 | ||
| KRYS | KRYSTAL BIOTECH INC | $296.70 | $104.18 | 184.79% | 38.28x | 37.74x | 20.82x | 6.85x | 1.67x | $237.38M | 2.73% | $1.28B | 43.59 | $8.25B | 38.58 | ||
| HALO | HALOZYME THERAPEUTICS INC | $65.19 | $70.51 | -7.55% | 24.69x | 7.90x | 5.59x | 157.61x | 0.40x | $644.59M | 8.25% | $48.81M | 0.41 | $9.70B | 16.93 | ||
| VCEL | VERICEL CORP | $35.13 | $8.36 | 320.03% | 106.45x | 79.18x | 6.40x | 5.03x | 1.86x | $24.75M | 1.40% | $354.64M | 7.05 | $1.78B | 50.99 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $11.00 | $16.63 | -33.85% | 5.37x | 22.19x | 5.25x | 3.16x | 0.70x | $56.42M | 8.78% | $205.80M | 3.52 | $555.82M | 3.84 | ||
| RPRX | ROYALTY PHARMA PLC | $50.20 | $42.89 | 17.05% | 26.28x | 9.49x | 8.99x | 2.91x | 0.54x | $2.34B | 10.68% | $9.94B | 22.75 | $37.28B | 32.04 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $4.19 | $3.08 | 36.13% | 17.46x | 15.35x | 2.57x | 4.05x | 0.82x | $4.11M | 1.22% | $82.33M | 1.03 | $269.74M | 12.70 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $226.96 | $50.02 | 353.71% | 482.89x | 9.32x | 3.17x | 3.14x | 1.66x | $1.30B | 9.24% | $4.53B | 73.22 | $17.80B | 26.37 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $56.93 | $16.46 | 245.97% | 58.09x | 51.61x | 5.78x | 7.23x | 1.78x | $164.23M | 3.77% | $605.69M | 7.92 | $4.20B | 37.67 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $31.42 | $36.10 | -12.96% | 11.38x | 8.80x | 2.08x | 2.09x | 0.52x | $347.89M | 19.26% | $870.22M | 15.14 | $1.23B | 4.82 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $210.33 | $86.32 | 143.66% | 32.66x | 22.80x | 15.17x | 4.12x | 1.43x | $48.09M | 1.18% | $1.02B | 52.60 | $4.47B | 22.42 | ||
| APLS | APELLIS PHARMACEUTICALS INC | $41.01 | $4.98 | 723.14% | 227.83x | -34.76x | 5.15x | 14.16x | 3.57x | $45.01M | 0.87% | $370.15M | 2.93 | $5.25B | 74.99 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $54.12 | $42.44 | 27.53% | 38.66x | 11.98x | 3.21x | 1.68x | 0.54x | $767.06M | 7.36% | $6.21B | 32.27 | $8.82B | 18.28 | ||
| TECH | BIO-TECHNE CORP | $50.91 | $16.89 | 201.35% | 71.70x | 25.18x | 6.57x | 3.82x | 1.36x | $269.60M | 3.39% | $2.09B | 13.34 | $8.05B | 31.45 | ||
| SPRO | SPERO THERAPEUTICS INC | $2.51 | $4.96 | -49.44% | 16.73x | 3.67x | 2.11x | 2.46x | 0.21x | -$12.62M | -8.96% | $59.02M | 1.05 | $107.94M | 12.22 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $425.00 | $179.91 | 136.23% | 24.99x | 21.82x | 8.84x | 5.57x | 1.70x | $3.71B | 3.44% | $19.36B | 76.20 | $104.36B | 19.35 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $31.17 | $15.03 | 107.38% | 17.81x | 15.10x | 6.47x | 3.99x | 1.98x | $208.61M | 5.47% | $954.27M | 7.80 | $3.10B | 9.63 | ||
| UTHR | UNITED THERAPEUTICS CORP | $569.18 | $269.71 | 111.03% | 19.44x | 19.30x | 7.81x | 4.09x | 1.80x | $1.02B | 4.11% | $5.90B | 135.66 | $22.88B | 13.35 | ||
| EXEL | EXELIXIS INC | $46.21 | $31.90 | 44.87% | 14.81x | 14.73x | 5.03x | 6.00x | 1.08x | $917.69M | 7.69% | $1.94B | 7.49 | $11.56B | 10.95 | ||
| SRPT | SAREPTA THERAPEUTICS INC | $20.80 | $6.95 | 199.39% | 34.67x | 6.53x | 1.00x | 1.46x | 1.97x | $109.24M | 5.00% | $1.51B | 14.34 | $2.77B | 33.46 | ||
| MDXG | MIMEDX GROUP INC | $3.69 | $1.82 | 102.24% | 17.57x | -271.32x | 1.41x | 2.26x | 1.89x | $69.36M | 12.66% | $242.94M | 1.64 | $407.43M | 7.48 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $709.10 | $444.61 | 59.49% | 16.66x | 15.05x | 4.94x | 2.37x | 1.16x | $4.11B | 5.58% | $31.42B | 302.15 | $74.08B | 12.90 | ||
| VCYT | VERACYTE INC | $40.76 | $9.19 | 343.40% | 36.72x | 44.57x | 5.98x | 2.42x | 4.52x | $155.34M | 4.79% | $1.34B | 16.90 | $3.03B | 26.31 | ||
| INCY | INCYTE CORP | $97.77 | $68.93 | 41.85% | 13.41x | 12.48x | 3.64x | 3.47x | 1.17x | $1.45B | 7.44% | $5.62B | 28.21 | $16.10B | 8.61 | ||
| PBYI | PUMA BIOTECHNOLOGY INC | $7.26 | $3.87 | 87.63% | 11.71x | 17.79x | 1.59x | 2.83x | 5.18x | $41.73M | 11.49% | $130.34M | 2.61 | $366.18M | 6.86 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.